ebook Munafa Stock Market Course + Intraday & FNO calls  

       

EDIT NEWS why is Editas Medicine, Inc. price falling or rising

EDIT NEWS reasons for why stock price of Editas Medicine, Inc. is falling or rising

EDIT Editas Medicine is falling or rising technical reasons

Technical analysis forecast for Editas Medicine Stock is that its in a downtrend for shortterm, and I will avoid taking a BUY or a LONG trade in this stock. Look for opportunities to sell or SHORT Editas Medicine EDIT at this time. Stock is falling and might fall more.

It appears as if Editas Medicine EDIT gave a large move recently.

Stock of Editas Medicine (EDIT) is trading below an important moving average line, but it crossed this line recently, which means that it could show a small or a large recovery soon enough depending on its trend.

My analysis of Editas Medicine is bearish for shortterm, but trade for tomorrow is selective. Take a sell trade only if Editas Medicine stays below 2.6, but if it comes above 2.6, then a intra day buy could be more profitable.
If you take a sell trade below 2.6, then use 2.6 as stoploss and 2.3 as target. However if you take a buy trade in Editas Medicine, then use 2.6 as stoploss and 2.77 as target.

EDIT Editas Medicine is falling or rising NEWS fundamental reasons

Bank deposits, credit shrink in fortnight to September 15 Outstanding bank deposits and advances declined significantly during the fortnight ending September 15. Deposits fell by Rs 2.49 lakh crore due to the maturing of high-cost bulk deposits. Deposit growth slowed to 17.3%, while credit growth also dropped to - NEWS as on 2026-09-25 indiatimes.com

Credit card spends fall 2.8% to ?2.02 trillion in August, shows RBI data Credit card spending fell to Rs 2.02 trillion in August as online spends declined 7 per cent, while the number of outstanding cards rose to 124.05 million - NEWS as on 2026-09-24 business-standard.com

Banks likely to deploy FCNR(B) liquidity in coming months as festive credit demand rises: RBI Deputy Guv Reserve Bank Deputy Governor Rohit Jain stated that banks are expected to deploy additional liquidity from FCNR(B) deposits. This deployment is likely driven by anticipated strong credit demand during the festive season. The RBI will not direct banks towar - NEWS as on 2026-09-24 indiatimes.com

UPI MDR from Oct 15: Should you switch from UPI to debit or credit cards? Before switching to cards, users should understand which UPI payments attract MDR and who actually bears the cost. - NEWS as on 2026-09-23 business-standard.com

Crisil Rating assigns 'AA-/A1+' rating to credit facilities of SG Finserve SG Finserve said that Crisil Rating has assigned its 'Crisil AA-/Stable/Crisil A1+' ratings to the bank facilities of the company. - NEWS as on 2026-09-22 business-standard.com

The rise of asset-backed borrowing in India's credit ecosystem Asset-backed borrowing is gaining traction in India's credit market, particularly through gold-backed lending, which provides essential liquidity without needing to sell investments immediately. The rise of digital platforms is making these services more a - NEWS as on 2026-09-21 indiatimes.com

IDFC FIRST Bank removes forex markup on all credit cards: What you save Existing as well as new cardholders will get zero forex markup automatically, without upgrading their cards or meeting a spending threshold - NEWS as on 2026-09-18 business-standard.com

'Enabling environment of West Bengal will help business and credit growth' SBI's Kolkata Circle sees 18% credit growth as MSMEs, housing, agriculture and infrastructure drive lending demand - NEWS as on 2026-09-17 business-standard.com

Motilal Oswal Financial Services receives upgrade in LT credit ratings From India Ratings and Research - NEWS as on 2026-09-16 business-standard.com

More announcements and NEWS

EDIT Editas Medicine, Inc. current price & indicator signals

Moving Averages for Editas Medicine, Inc.

  • 5Day Average: 2.69
  • 12Day Average: 2.71
  • 20Day Average: 2.82
  • 50Day Average: 2.85
  • 100Day Average: 2.9
  • 150Day Average: 2.83
  • 200Day Average: 2.64

EDIT Indicators & signals

Indicator MACD (12,26,9)

2.72, 2.82, -0.08
Indicator MACD is in negative zone

Indicator ADX (14)

6.67, 30.43, 34.78
Indicator ADX is indicating that momentum is weak.
Momentum is towards selling.

Indicator RSI (14)

Current RSI is: 45
Indicator RSI is indicating buying momentum and stock might rise.

Recent prices of EDIT Editas Medicine, Inc. are as follows: Daily volume is divided by 10 day averaged volume

Date Close Range Change % Volume
28 Mon Sep 2026 2.51 2.42 to 2.55 -3.09% 0.54 times
25 Fri Sep 2026 2.59 2.57 to 2.80 -5.82% 0.66 times
24 Thu Sep 2026 2.75 2.55 to 2.76 2.23% 0.55 times
23 Wed Sep 2026 2.69 2.67 to 3.14 -7.88% 1.26 times
22 Tue Sep 2026 2.92 2.81 to 2.93 3.18% 0.56 times
21 Mon Sep 2026 2.83 2.70 to 2.89 4.81% 0.61 times
18 Fri Sep 2026 2.70 2.68 to 2.83 -0.74% 4.16 times
17 Thu Sep 2026 2.72 2.71 to 2.94 0.37% 0.86 times
16 Wed Sep 2026 2.71 2.63 to 2.73 3.04% 0.61 times
15 Tue Sep 2026 2.63 2.59 to 2.99 -4.01% 0.32 times
14 Mon Sep 2026 2.74 2.66 to 2.82 1.48% 0.41 times
11 Fri Sep 2026 2.70 2.62 to 2.72 1.89% 0.6 times

Videos related to: EDIT NEWS why is Editas Medicine, Inc. price falling or rising

Hindi Basics How To Trade In FnO Futures Options Stock Market

EDIT NEWS why is Editas Medicine, Inc. price falling or rising

 

Back to top